Skip to main content
Top
Published in: Clinical Rheumatology 6/2022

01-06-2022 | Ultrasound | Original Article

Ultrasound-detected tenosynovitis as a risk factor for flares in rheumatoid arthritis patients in clinical remission

Authors: Johana Zacariaz Hereter, Javier Eduardo Rosa, Florencia Beatriz Mollerach, Josefina Marin, Leandro Gabriel Ferreyra Garrott, Martin Brom, Enrique Roberto Soriano

Published in: Clinical Rheumatology | Issue 6/2022

Login to get access

Abstract

Background

Our objective was to investigate the value of ultrasound (US) detected synovitis and tenosynovitis as risk factors for short term flare in rheumatoid arthritis (RA) patients in clinical remission.

Methods

Consecutive RA patients in clinical remission (DAS28 ERS < 2.6) for at least 3 months underwent Power Doppler ultrasound (PDUS) examination of 1st to 6th extensor compartments at the wrist, 2nd to 5th finger flexor, posterior tibial tendon, and peroneal tendons. To assess synovitis, carpal joints, 1st to 5th metacarpophalangeal (MCP) joints, and 2nd to 5th interphalangeal proximal (IPP) joints were bilaterally examined. Synovitis and tenosynovitis were defined according to OMERACT. Patients were followed for 1 year. Disease flare was defined as an increase in disease activity generating the need for a change in therapy by the attending rheumatologist.

Results

Ninety patients were included. After 1 year of follow-up, 26 patients (29%) experienced a flare. At baseline 39%, 23% and 8% had US-detected synovitis, tenosynovitis or both, respectively.
In the 1-year period after the baseline US examination, US-detected tenosynovitis (RR: 4.9; 95% CI: 2.2–10.8) was associated with an increased risk of exacerbation. This association was not shown with US-detected synovitis (RR: 1.3; 95% CI: 0.76–2.2). In the multivariate analysis, only subclinical tenosynovitis (OR: 9.8; 95% CI: 2.5–39.1; p = 0.001) and baseline DAS28 (OR: 5.7; 95% CI: 1.1–31.6; p = 0.047) were significantly associated with an increased risk of having a flare.

Conclusion

In our study, subclinical tenosynovitis was associated with disease flare in patients with RA in clinical remission.

Key Points

• Synovitis and tenosynovitis are risk factors for short term flare in RA patients in clinical remission.
• Subclinical tenosynovitis, but not synovitis, was associated with disease flare in patients with unstable remission.
• Ultrasound-detected tenosynovitis could be useful to predict relapses in RA patients in clinical remission.
Literature
3.
go back to reference Naredo E, Iagnocco A (2016) One year in review: ultrasound in arthritis. Clin Exp Rheumatol 34(1):1–10PubMed Naredo E, Iagnocco A (2016) One year in review: ultrasound in arthritis. Clin Exp Rheumatol 34(1):1–10PubMed
4.
go back to reference Bruyn GA, Iagnocco A, Naredo E, Balint PV, Gutierrez M, Hammer HB, Collado P, Filippou G, Schmidt WA, Jousse-Joulin S, Mandl P, Conaghan PG, Wakefield RJ, Keen HI, Terslev L, D’Agostino MA (2019) OMERACT ultrasound working group. Omeract definitions for ultrasonographic pathologies and elementary lesions of rheumatic disorders 15 years on. J Rheumatol 46(10):1388–393. https://doi.org/10.3899/jrheum.181095CrossRefPubMed Bruyn GA, Iagnocco A, Naredo E, Balint PV, Gutierrez M, Hammer HB, Collado P, Filippou G, Schmidt WA, Jousse-Joulin S, Mandl P, Conaghan PG, Wakefield RJ, Keen HI, Terslev L, D’Agostino MA (2019) OMERACT ultrasound working group. Omeract definitions for ultrasonographic pathologies and elementary lesions of rheumatic disorders 15 years on. J Rheumatol 46(10):1388–393. https://​doi.​org/​10.​3899/​jrheum.​181095CrossRefPubMed
5.
go back to reference Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E et al (2006) Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 54(12):3761–3773. https://doi.org/10.1002/art.22190CrossRefPubMed Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E et al (2006) Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 54(12):3761–3773. https://​doi.​org/​10.​1002/​art.​22190CrossRefPubMed
7.
go back to reference Kawashiri SY, Suzuki T, Nakashima Y, Horai Y, Okada A, Iwamoto N et al (2014) Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: power Doppler subclinical synovitis is associated with bone erosion. Rheumatology (Oxford) 53(3):562–569. https://doi.org/10.1093/rheumatology/ket405CrossRef Kawashiri SY, Suzuki T, Nakashima Y, Horai Y, Okada A, Iwamoto N et al (2014) Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: power Doppler subclinical synovitis is associated with bone erosion. Rheumatology (Oxford) 53(3):562–569. https://​doi.​org/​10.​1093/​rheumatology/​ket405CrossRef
9.
go back to reference Foltz V, Gandjbakhch F, Etchepare F, Rosenberg C, Tanguy ML, Rozenberg S et al (2012) Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum 64(1):67–76. https://doi.org/10.1002/art.33312CrossRefPubMed Foltz V, Gandjbakhch F, Etchepare F, Rosenberg C, Tanguy ML, Rozenberg S et al (2012) Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum 64(1):67–76. https://​doi.​org/​10.​1002/​art.​33312CrossRefPubMed
11.
go back to reference Nguyen H, Ruyssen-Witrand A, Gandjbakhch F, Constantin A, Foltz V, Cantagrel A (2014) Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis. Rheumatology (Oxford) 53(11):2110–2118. https://doi.org/10.1093/rheumatology/keu217CrossRef Nguyen H, Ruyssen-Witrand A, Gandjbakhch F, Constantin A, Foltz V, Cantagrel A (2014) Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis. Rheumatology (Oxford) 53(11):2110–2118. https://​doi.​org/​10.​1093/​rheumatology/​keu217CrossRef
14.
go back to reference Baillet A, Gaujoux-Viala C, Mouterde G, Pham T, Tebib J, Saraux A et al (2011) Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford) 50(6):1137–1147. https://doi.org/10.1093/rheumatology/ket405CrossRef Baillet A, Gaujoux-Viala C, Mouterde G, Pham T, Tebib J, Saraux A et al (2011) Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford) 50(6):1137–1147. https://​doi.​org/​10.​1093/​rheumatology/​ket405CrossRef
18.
go back to reference McAlindon T, Kissin E, Nazarian L, Ranganath V, Prakash S, Taylor M et al (2012) American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care Res (Hoboken) 64(11):1625–1640. https://doi.org/10.1002/acr.21836CrossRef McAlindon T, Kissin E, Nazarian L, Ranganath V, Prakash S, Taylor M et al (2012) American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care Res (Hoboken) 64(11):1625–1640. https://​doi.​org/​10.​1002/​acr.​21836CrossRef
19.
go back to reference Bellis E, Scire CA, Carrara G, Adinolfi A, Batticciotto A, Bortoluzzi A et al (2016) Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: results from the observational study STARTER of the Italian Society for Rheumatology. Rheumatology (Oxford) 55(10):1826–1836. https://doi.org/10.1093/rheumatology/kew258CrossRef Bellis E, Scire CA, Carrara G, Adinolfi A, Batticciotto A, Bortoluzzi A et al (2016) Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: results from the observational study STARTER of the Italian Society for Rheumatology. Rheumatology (Oxford) 55(10):1826–1836. https://​doi.​org/​10.​1093/​rheumatology/​kew258CrossRef
20.
go back to reference Filippou G, Sakellariou G, Scirè CA, Carrara G, Rumi F, Bellis E et al (2018) The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the STARTER study. Ann Rheum Dis 77(9):1283–1289. https://doi.org/10.1136/annrheumdis-2018-213217CrossRefPubMed Filippou G, Sakellariou G, Scirè CA, Carrara G, Rumi F, Bellis E et al (2018) The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the STARTER study. Ann Rheum Dis 77(9):1283–1289. https://​doi.​org/​10.​1136/​annrheumdis-2018-213217CrossRefPubMed
23.
go back to reference Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. ArthritisRheum 62(9):2569–2581. https://doi.org/10.1002/art.27584CrossRef Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. ArthritisRheum 62(9):2569–2581. https://​doi.​org/​10.​1002/​art.​27584CrossRef
24.
go back to reference Prevoo ML, van ’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–8. https://doi.org/10.1002/art.1780380107CrossRefPubMed Prevoo ML, van ’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–8. https://​doi.​org/​10.​1002/​art.​1780380107CrossRefPubMed
31.
go back to reference Bruyn GA, Hanova P, Iagnocco A, d’Agostino MA, Möller I, Terslev L, Backhaus M, Balint PV, Filippucci E, Baudoin P, van Vugt R, Pineda C, Wakefield R, Garrido J, Pecha O, Naredo E (2014) OMERACT ultrasound task force. Ultrasound definition of tendon damage in patients with rheumatoid arthritis. Results of a OMERACT consensus-based ultrasound score focussing on the diagnostic reliability. Ann RheumDis 73(11):1929–34. https://doi.org/10.1136/annrheumdis-2013-203596CrossRef Bruyn GA, Hanova P, Iagnocco A, d’Agostino MA, Möller I, Terslev L, Backhaus M, Balint PV, Filippucci E, Baudoin P, van Vugt R, Pineda C, Wakefield R, Garrido J, Pecha O, Naredo E (2014) OMERACT ultrasound task force. Ultrasound definition of tendon damage in patients with rheumatoid arthritis. Results of a OMERACT consensus-based ultrasound score focussing on the diagnostic reliability. Ann RheumDis 73(11):1929–34. https://​doi.​org/​10.​1136/​annrheumdis-2013-203596CrossRef
Metadata
Title
Ultrasound-detected tenosynovitis as a risk factor for flares in rheumatoid arthritis patients in clinical remission
Authors
Johana Zacariaz Hereter
Javier Eduardo Rosa
Florencia Beatriz Mollerach
Josefina Marin
Leandro Gabriel Ferreyra Garrott
Martin Brom
Enrique Roberto Soriano
Publication date
01-06-2022
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 6/2022
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-022-06079-1

Other articles of this Issue 6/2022

Clinical Rheumatology 6/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.